电针治疗结直肠癌患者奥沙利铂所致周围神经病变:单盲随机假针对照试验
电针组每周治疗1次,较假针组显著减轻化疗期间周围神经病变严重程度,并改善躯体、角色和社会功能,振动觉与轻触觉无显著差异,安全性良好。
要点
- 电针每周1次可减轻奥沙利铂化疗期间周围神经病变严重程度
- 电针改善患者躯体功能、角色功能和社会功能
- 振动觉与轻触觉测试未见显著差异,慢性CIPN作用尚不明确
核心结论
- 电针对结直肠癌患者急性奥沙利铂所致周围神经病变显示初步有效性和安全性证据。
- 对慢性CIPN的作用仍不明确,需进一步研究验证。
研究设计与样本
- 电针组每周接受1次电针,假针组接受假针,治疗12周,随访12周。
主要发现
- 与假针组相比,电针组在化疗期间CIPN严重程度显著减轻。
- 电针组躯体功能、角色功能和社会功能改善。
- 振动觉和轻触觉测试两组无显著差异。
- 电针在化疗期间安全、可行且为患者接受。
临床怎么用
- 对接受奥沙利铂化疗的结直肠癌患者,可考虑每周1次电针以减轻急性CIPN严重程度并改善功能。
- 对振动觉和轻触觉障碍的改善证据不足,慢性CIPN的疗效尚不明确。
局限性
- 单盲设计,对慢性CIPN的作用未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oxaliplatin-based chemotherapy is a major first-line conventional therapy for advanced and metastatic colorectal cancer (CRC). However, oxaliplatin causes chemotherapy-induced peripheral neuropathy (CIPN). Acupuncture has long been used to alleviate limb numbness in Chinese medicine practice. AIM: The aim of this study was to examine the efficacy and safety of electroacupuncture (EA) for the alleviation of CIPN in CRC patients. DESIGN: This was a pilot single-blinded, randomized, sham-controlled trial. SETTING/PARTICIPANTS: Sixty eligible patients, who had been diagnosed with CRC and were undergoing oxaliplatin-based chemotherapy, were randomized in a ratio of 1:1 to the EA intervention group or sham acupuncture (SA) control group. During a 12-week treatment period, patients in the EA group received EA once a week, while patients in the SA group received SA; both groups were followed up for 12 weeks. RESULTS: Compared with the SA group, the EA group exhibited significant alleviation of CIPN severity during chemotherapy. Moreover, EA also improved the physical function, role function, and social function of CRC patients. However, there were no significant differences in tests of vibration or light touch sensation. In addition, EA appeared to be a safe treatment for CIPN and was both feasible and acceptable to CRC patients during chemotherapy. CONCLUSION: This study showed preliminary evidence for the efficacy and safety of EA in acute CIPN among CRC patients, although further studies are needed to verify these effects and to further explore the potential role of EA in chronic CIPN (effects on which remain unclear). TRIAL REGISTRATION NUMBER: NCT03582423 (ClinicalTrials.gov).
引用
- Chan K, Lui L, Lam Y, et al. Efficacy and safety of electroacupuncture for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: a single-blinded, randomized, sham-controlled trial. Acupunct Med. 2022. PMID: 36325677. doi:10.1177/09645284221125421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。